Viewing Study NCT05021120


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT05021120
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2021-08-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Sponsor: Akesobio Australia Pty Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-10-12
Start Date Type: ACTUAL
Primary Completion Date: 2024-10-01
Primary Completion Date Type: ACTUAL
Completion Date: 2025-04-01
Completion Date Type: ACTUAL
First Submit Date: 2021-08-12
First Submit QC Date: None
Study First Post Date: 2021-08-25
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-11-27
Last Update Post Date: 2025-12-04
Last Update Post Date Type: ESTIMATED